Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
Saturday, April 2, 2011 - 17:30
in Health & Medicine
Berlin, Germany, Saturday 02 April 2011: Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment (SVR12).1